Methylenedioxypyrovalerone

MDPV
Clinical data
Other namesMDPV; 3′,4′-Methylenedioxy-α-(pyrrolidin-1-yl)valerophenone; MDPK; MD-α-PVP
Routes of
administration		Oral, insufflation, intravenous, rectal, vaporization
Drug classStimulant; Norepinephrine–dopamine reuptake inhibitor
Legal status
Legal status
  • AU: S9 (Prohibited substance)
  • BR: Class F1 (Prohibited narcotics)
  • CA: Schedule I
  • DE: Anlage II (Authorized trade only, not prescriptible)
  • UK: Class B
  • US: Schedule I
  • UN: Psychotropic Schedule II
  • Illegal in Austria, Belgium, Bulgaria, Croatia, Cyprus, Czech Republic, Denmark, Estonia, France, Hungary, Ireland, Finland, Italy, Latvia, Luxembourg, Norway, Poland, Portugal, Romania, Russia, Slovakia, Slovenia, Sweden, Turkey, Ukraine.
Pharmacokinetic data
MetabolismHepatic
ExcretionPrimarily urine (renal)
Identifiers
  • 1-(1,3-Benzodioxol-5-yl)-2-(pyrrolidin-1-yl)pentan-1-one
CAS Number
PubChem CID
ChemSpider
UNII
KEGG
CompTox Dashboard (EPA)
Chemical and physical data
FormulaC16H21NO3
Molar mass275.348 g·mol−1
3D model (JSmol)
ChiralityRacemic mixture
  • O=C(C(CCC)N1CCCC1)C2=CC=C3C(OCO3)=C2
  • InChI=1S/C16H21NO3/c1-2-5-13(17-8-3-4-9-17)16(18)12-6-7-14-15(10-12)20-11-19-14/h6-7,10,13H,2-5,8-9,11H2,1H3 Y
  • Key:SYHGEUNFJIGTRX-UHFFFAOYSA-N Y
  (verify)

Methylenedioxypyrovalerone (MDPV) is a stimulant of the cathinone class that acts as a norepinephrine–dopamine reuptake inhibitor (NDRI).

This article is issued from Wikipedia. The text is available under Creative Commons Attribution-Share Alike 4.0 unless otherwise noted. Additional terms may apply for the media files.